Eupraxia Pharmaceuticals Raises US$63.2 Million to Advance GI Pipeline and Commercial Readiness
TipRanks (Fri, 20-Feb 3:47 PM ET)
Globe Newswire (Fri, 20-Feb 3:10 PM ET)
TipRanks (Fri, 20-Feb 6:32 AM ET)
Market Chameleon (Thu, 19-Feb 3:22 AM ET)
Eupraxia Pharmaceuticals stock falls after pricing $55M public offering
Seeking Alpha News (Thu, 19-Feb 5:44 AM ET)
Eupraxia Raises US$55 Million to Accelerate EP-104GI and GI Pipeline
TipRanks (Thu, 19-Feb 3:09 AM ET)
Globe Newswire (Thu, 19-Feb 2:18 AM ET)
Eupraxia Pharmaceuticals Plans Public Offering to Fund GI Drug Pipeline
TipRanks (Wed, 18-Feb 5:48 PM ET)
Eupraxia Pharmaceuticals files for proposed public share offering
Seeking Alpha News (Wed, 18-Feb 4:06 PM ET)
Eupraxia Pharmaceuticals Announces Proposed Public Offering
Globe Newswire (Wed, 18-Feb 4:01 PM ET)
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.
Eupraxia Pharmaceuticals trades on the NASDAQ stock market under the symbol EPRX.
As of February 20, 2026, EPRX stock price climbed to $8.50 with 598,034 million shares trading.
EPRX has a beta of 1.12, meaning it tends to be more sensitive to market movements. EPRX has a correlation of 0.14 to the broad based SPY ETF.
EPRX has a market cap of $430.51 million. This is considered a Small Cap stock.
EPRX has outperformed the market in the last year with a price return of +139.2% while the SPY ETF gained +14.1%. EPRX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +36.9% and +1.8%, respectively, while the SPY returned +6.0% and -0.2%, respectively.
EPRX support price is $7.73 and resistance is $8.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EPRX shares will trade within this expected range on the day.
